• Revenue increased 30.7% to $48.2m, driven by acquisitions and organic growth
• EBITDA increased 60.1% to $8.3m, reflecting operating leverage and improved margins
• Debt-free with $15.2m cash, providing financial flexibility

Austco Healthcare Ltd (ASX: AHC) reported robust 1H-26 results, with revenue increasing 30.7% to $48.2 million and EBITDA rising 60.1% to $8.3 million. The company's performance was driven by the successful integration of recent acquisitions, which expanded its regional footprint and product capabilities, particularly in Australia/New Zealand and North America. Austco also continued to see organic growth, reflecting the strong tailwinds in the global healthcare market, including the ongoing digitalization of the sector and rising demand for safer, more efficient care. The company's operating leverage was on display, with EBITDA margins improving to 17.1% from 14.0% in the prior corresponding period. Austco maintained a strong balance sheet, ending the half with $15.2 million in cash and no debt, providing financial flexibility to fund ongoing investment in innovation, as well as selective M&A opportunities aligned with the company's strategic priorities. Looking ahead, Austco remains focused on driving continuous innovation, expanding its recurring revenue base, enhancing margins through operational efficiency, and selectively pursuing value-accretive acquisitions to strengthen its capabilities and market presence across core regions.

Austco expects to maintain its focus on execution, balance sheet strength, and long-term value creation within a dynamic healthcare funding environment.